MAUDE Adverse Event Report: ETHICON INC. DERMABOND MINI HV 0.36ML VIAL - 12EA; ADHESIVE, TOPICAL SKIN

Model Number	DHVM12
Medical Device Problem Code	Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code	Rash (2033)
Date of Event	10/27/2021
Type of Reportable Event	Serious Injury
Event or Problem Description
It was reported a patient underwent an abdominoplasty on (b)(6) 2021 and topical skin adhesive was used.Post-op patient broke out in a rash.Rash to incision line, severe itching.Medrol does pack prescribed on (b)(6) 2021; steroid shot administered on (b)(6) 2021.Current patient status: unresolved itching, rash improved on (b)(6) 2021.There was no further information reported.Device is not available for return.Additional information has been requested.
Additional Manufacturer Narrative
Product complaint # (b)(4).Additional information has been requested however not received.If further details are received at a later date a supplemental medwatch will be sent.If photo is available, please label and provided.Please describe how was the adhesive was applied.What prep was used prior to, during or after dermabond use? was a dressing placed over the incision? if so, what type of cover dressing used? is the patient hypersensitive or have allergies to cyanoacrylate or formaldehyde? is the patient hypersensitive to pressure sensitive adhesives? were any patch or sensitivity tests performed? patient demographics: id, gender, age or date of birth; bmi.Patient pre-existing medical conditions (ie.Allergies, history of reactions).No product is available.A manufacturing record evaluation was performed for the finished device lot, and no non-conformances were identified.
Additional Manufacturer Narrative
Product complaint # (b)(4).Additional information has been requested however not received.If further details are received at a later date a supplemental medwatch will be sent.If photo is available, please label and provided.Please describe how was the adhesive was applied.What prep was used prior to, during or after dermabond use? was a dressing placed over the incision? if so, what type of cover dressing used? is the patient hypersensitive or have allergies to cyanoacrylate or formaldehyde? is the patient hypersensitive to pressure sensitive adhesives? were any patch or sensitivity tests performed? patient demographics: id, gender, age or date of birth; bmi.Patient pre-existing medical conditions (ie.Allergies, history of reactions).No product is available.A manufacturing record evaluation was performed for the finished device lot, and no non-conformances were identified.
Event or Problem Description
It was reported a patient underwent an abdominoplasty on (b)(6) 2021 and topical skin adhesive was used.Post-op patient broke out in a rash.Rash to incision line, severe itching.Medrol does pack prescribed on (b)(6) 2021; steroid shot administered on (b)(6) 2021.Current patient status: unresolved itching, rash improved on (b)(6) 2021.There was no further information reported.Device is not available for return.Additional information has been requested.
Additional Manufacturer Narrative
Product complaint # (b)(4).This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Additional information: a2, a3 additional information was requested, and the following was obtained: additional information requested for patient name: (b)(6).Procedure name: abdominoplasty.Procedure date: (b)(6) 2021.If photo is available, please label and provide.Please describe how was the adhesive was applied.The dermabond was applied using a sterile technique after the incision was cleaned with normal saline in the operating room at the end of the procedure.What prep was used prior to, during or after dermabond use? chloraprep.Was a dressing placed over the incision? if so, what type of cover dressing used? an abd pad was applied to the incision.Is the patient hypersensitive or have allergies to cyanoacrylate or formaldehyde? no known allergies.Is the patient hypersensitive to pressure sensitive adhesives? no.Were any patch or sensitivity tests performed? no.Patient demographics: id, gender, age or date of birth; (b)(6), female, 46, (b)(6) 1975.Patient pre-existing medical conditions (ie.Allergies, history of reactions) none.

• Brand Name: DERMABOND MINI HV 0.36ML VIAL - 12EA
• Common Device Name: ADHESIVE, TOPICAL SKIN
• Manufacturer (Section D): ETHICON INC.; 1000 route 202; raritan NJ 08869
• Manufacturer (Section G): ETHICON INC.-SAN LORENZO PR; road 183, km. 8.3; san lorenzo 00754
• Manufacturer Contact: elba bello ; 1000 route 202; raritan, NJ 08869
• MDR Report Key: 12962243
• Report Number: 2210968-2021-12436
• Device Sequence Number: 16607994
• Product Code: MPN
• UDI-Device Identifier: 10705031203525
• UDI-Public: 10705031203525
• Combination Product (Y/N): N
• Initial Reporter Country: US
• PMA/510(K) Number: K152096
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Serviced by Third Party (Y/N): Unknown
• Reporter Type: Manufacturer
• Report Source: Health Professional,User Facility,Company Representative
• Initial Reporter Occupation: Other
• Type of Report: Initial,Followup
• Report Date (Section B): 04/08/2022

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: No
• Operator of Device: Health Professional
• Device Expiration Date: 05/31/2023
• Device Model Number: DHVM12
• Device Catalogue Number: DHVM12
• Device Lot Number: RGBDJP
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: No
• Type of Report(Section G): Thirty-Day
• Initial Date Received by Manufacturer: 11/16/2021
• Supplement Date Received by Manufacturer: 03/31/2022
• Initial Report FDA Received Date: 12/08/2021
• Supplement Report FDA Received Date: 04/08/2022
• Was Device Evaluated by Manufacturer? (Y/N): Device Not Returned to Manufacturer
• Date Device Manufactured: 06/16/2021
• Is the Device Labeled for Single Use? (Y/N): Yes
• Usage of Device: Initial
• Patient Sequence Number: 1
• Outcome Attributed to Adverse Event: Required Intervention
• Patient Age: 46 YR
• Patient Sex: Female